Matt Segall, Optibrium
"At least for the forseeable future, progress is about that combination between human expertise and new computational & AI algorithms. It's this combination that will give the best outcomes." Matt Segall was one of the pioneers of applying computational physics techniques in a drug discovery and development setting. Now CEO of Optibrium, Matt joined us on Careers in Discovery to talk about his career, the need to solve real problems and the highs & lows of life in Biotech. Enjoy!